Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;236(2):931-945.
doi: 10.1002/jcp.29903. Epub 2020 Jun 24.

Involvement of GPX4 in irisin's protection against ischemia reperfusion-induced acute kidney injury

Affiliations

Involvement of GPX4 in irisin's protection against ischemia reperfusion-induced acute kidney injury

Jia Zhang et al. J Cell Physiol. 2021 Feb.

Abstract

Ischemia reperfusion (I/R)-induced acute kidney injury (AKI) is a common and serious condition. Irisin, an exercise-induced hormone, improves mitochondrial function and reduces reactive oxygen species (ROS) production. Glutathione peroxidase 4 (GPX4) is a key regulator of ferroptosis and its inactivation aggravates renal I/R injury by inducing ROS production. However, the effect of irisin on GPX4 and I/R-induced AKI is still unknown. To study this, male adult mice were subjected to renal I/R by occluding bilateral renal hilum for 30 min, which was followed by 24 hr reperfusion. Our results showed serum irisin levels were decreased in renal I/R mice. Irisin (250 μg/kg) treatment alleviated renal injury, downregulated inflammatory response, improved mitochondrial function, and reduced ER stress and oxidative stress after renal I/R, which were associated with upregulation of GPX4. Treated with RSL3 (a GPX4 inhibitor) abolished irisin's protective effect. Thus, irisin attenuates I/R-induced AKI through upregulating GPX4.

Keywords: AKI; GPX4; ROS; irisin; renal I/R.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Askari, H., Rajani, S. F., Poorebrahim, M., Haghi-Aminjan, H., Raeis-Abdollahi, E., & Abdollahi, M. (2018). A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: An introductory review. Pharmacological Research, 129, 44-55. https://doi.org/10.1016/j.phrs.2018.01.012
    1. Basile, D. P., Anderson, M. D., & Sutton, T. A. (2012). Pathophysiology of acute kidney injury. Comprehensive Physiology, 2(2), 1303-1353. https://doi.org/10.1002/cphy.c110041
    1. Batirel, S., Bozaykut, P., Mutlu Altundag, E., Kartal Ozer, N., & Mantzoros, C. S. (2014). The effect of Irisin on antioxidant system in liver. Free Radical Biology and Medicine, 75(Suppl. 1), S16. https://doi.org/10.1016/j.freeradbiomed.2014.10.592
    1. Bi, J., Yang, L., Wang, T., Zhang, J., Li, T., Ren, Y., … Wu, R. (2020). Irisin improves autophagy of aged hepatocytes via increasing telomerase activity in liver injury. Oxidative Medicine and Cellular Longevity, 2020, 6946037. https://doi.org/10.1155/2020/6946037
    1. Bi, J., Zhang, J., Ren, Y., Du, Z., Li, T., Wang, T., Zhang, L., … Wu, R. (2019). Irisin reverses intestinal epithelial barrier dysfunction during intestinal injury via binding to the integrin alphaVbeta5 receptor. Journal of Cellular and Molecular Medicine, 24, 996-1009. https://doi.org/10.1111/jcmm.14811

Publication types

Substances

LinkOut - more resources